# 4053
I can remember when Friday’s used to be quiet on the flu front.
Those days are gone, apparently.
In a statement from the National Public Health Service for Wales, we get word of the likely (limited) spread of a Tamiflu resistant strain of the H1N1 virus at the University Hospital in Cardiff.
Oseltamivir Resistance is generally caused by a mutation, known as H274Y, where a single amino acid substitution (histidine (H) to tyrosine (Y)) occurs at the neuraminidase position 274.
Thus far, we’ve only seen scattered reports of Tamiflu resistance around the world, but it is likely that we are missing some cases. The vast majority of H1N1 flu cases continue to respond well to the drug.
Of the nearly 60 known resistant samples detected till now, most were so-called `spontaneous mutations’ that occurred in patients taking the antiviral.
In other words, they were not believed to have involved the transmission of a mutated virus.
Even if transmission is established in this case it appears to have been limited to a handful of immunosuppressed patients, and for now remains more an object of scientific curiosity than a public health concern.
A big hat tip and thank you to LIsa at CIDRAP for passing this link on. They will no doubt have some coverage of this story tonight on the CIDRAP website.
News: Person to person spread of swine flu resistant to Tamiflu
20 November 2009
The National Public Health Service for Wales (NPHS) has found person-to-person spread of a strain of swine flu resistant to Tamiflu within a South Wales hospital.
Five patients on a unit treating patients with severe underlying health conditions at the University Hospital of Wales, Cardiff, have been diagnosed with swine flu resistant to Oseltamivir (Tamiflu).
Three appear to have acquired the infection in hospital.
Dr Roland Salmon, Director of the NPHS Communicable Disease Surveillance Centre, said: “The emergence of influenza A viruses that are resistant to Tamiflu is not unexpected in patients with serious underlying conditions and suppressed immune systems, who still test positive for the virus despite treatment.
“In this case, the resistant strain of swine flu does not appear to be any more severe than the swine flu virus that has been circulating since April.
“For the vast majority of people, Tamiflu has proved effective in reducing the severity of illness. Vaccination remains the most effective tool we have in preventing swine flu so I urge people identified as being at risk to look out for their invitation to be vaccinated by their GP surgery.”
Chief Medical Officer, Dr Tony Jewell, said: “We know that people with suppressed immune systems are more susceptible to the swine flu virus, which is why they are a priority group under the first phase of the vaccination programme in Wales which is progressing at pace.
“We have stringent processes in place for monitoring for antiviral resistance in the UK so that we can spot resistance early and the causes can be investigated and the cases managed. Identifying these cases shows that our systems are working so patients should be reassured.
“Treatment with Tamiflu is still appropriate for swine flu and people should continue to take Tamiflu when they are prescribed it.
“It’s also important that good hygiene practices are followed to further prevent the spread of the virus.”
All patients diagnosed with Tamiflu-resistant swine flu on the unit have been treated with an alternative antiviral.
All other patients on the unit have been tested for swine flu.
Patients have been isolated or are being cared for in a designated area for influenza cases and Cardiff and Vale University Health Board has ensured that all appropriate infection control measures are in place on the unit.
Patients and staff at the unit have been offered swine flu vaccination. Patients due to come into the unit for treatment are being advised to have the vaccination from their GP in advance of coming to the hospital.
Household contacts of the patients with swine flu are being followed up to ensure early and appropriate treatment is offered should symptoms of influenza develop.
Two patients with Tamiflu-resistant swine flu have recovered and have been discharged from hospital. One patient remains in critical care and two others continue to be treated on the ward.
Related Post:
- UK: Warning On Counterfeit Condoms
- HPA: Flu Activity In The UK
- HPA Norovirus Update
- UK: Three Whooping Cough Deaths In October
- Update: CCHF Patient In Scotland Dies
- UK: HPA Announcement On Novel Coronavirus Case
- UK: Probable Source Of Legionnaires Outbreak Indentified
- HPA Updates The Stoke-On-Trent Legionella Outbreak
- More Tales From The Crypto
- The Legionella Outbreak in South West Edinburgh
- HPA: Healthcare-Associated Infection (HCAI) Survey
- UK: Civil Threat Risk Assessment
- UK: Updated Pandemic Influenza Plan
- Another Yank From Oxford
- Another Message Of Import
- Lancet Study: TB Screening
- UK: Proposed Influenza Pandemic Preparedness Strategy
- UK: HPA Weekly Influenza Surveillance
- UK: HPA Influenza Report Week 4
- Eurosurveillance: Debating The D222G/N Mutation In H1N1
- UK: HPA Week 3 Influenza Report
- UK: HPA Influenza Report – Week 2
- UK: GPs Warned Over Bacterial Co-Infections With Flu
- UK: H1N1 `Swine’ Flu Found In Turkeys
- Eurosurveillance: Analysis Of Fatal H1N1 Cases In The UK
- ECDC: Multidrug Resistant Infections Increasing In Europe
- A Health Crisis In Slow Motion
- Referral: McKenna On Resistant Gonorrhea
- EID: Environmental NDM-1 Detected In Vietnam
- Referral: McKenna On Resistant UTIs
- MMWR: NDM-1 Transmission In Rhode Island
- ECDC Response Plan To Multi-Drug Resistant Gonorrhea
- WHO: Urgent Action Needed On Resistant Gonorrhea
- CDC Grand Rounds: Multidrug-Resistant Gonorrhea
- Video: Maryn McKenna On Antibiotic Resistance
- Indonesia: MOH Suspects H5N1 May Be Gaining Antiviral Resistance
- NPR Science Friday: McKenna On Resistant TB
- ECDC Comment On Drug Resistant TB In India
- NEJM: Oseltamivir Resistant H1N1 in Australia
- CIDRAP News: Signs Of Tamiflu Resistant H1N1 Spreading
- WER: Update On Anti-Viral Resistant Influenza
- CDDEP: Mapping Resistance
- ECDC: Risk Assessment On Australia’s Antiviral Resistant H1N1 Cluster
- Australia Reports Cluster Of Antiviral Resistant H1N1
- NDM-1: One Year Later
- The Global Spread Of Drug Resistant Salmonella
- Netherlands: Large Nosocomial KPC Outbreak
- IDSA: Educational Guidelines Lower Antibiotic Use
- Going, Going, Gonorrhea
- Declan Butler On Growing Mosquito Insecticide Resistance
- Canada Releases Tamiflu From National Emergency Stockpile
- Study: The Benefits Of Antiviral Therapy During the 2009 Pandemic
- Study: Adverse Events Associated With Oseltamivir Outpatient Treatment
- The CDC Responds To The Cochrane Group’s Tamiflu Study
- The Tamiflu Controversy Continues
- NEJM: Oseltamivir Resistant H1N1 in Australia
- CIDRAP News: Signs Of Tamiflu Resistant H1N1 Spreading
- Australia Reports Cluster Of Antiviral Resistant H1N1
- The WHO’s Flu Review
- CIDRAP: UK Findings Hint At Resistant Flu Strain
- Study: Oseltamivir-Resistant Pandemic Flu Cases In The US
- PLoS Medicine: Mono or Combo Antiviral Therapy?
- BMJ: Efficacy of Oseltamivir In Mild H1N1
- Study: Antiviral Therapy For H5N1
- Fitness Of Oseltamivir-Resistant A/H1N1/2009
- FDA Warns On Fake Tamiflu
- Study: Oseltamivir Treatment of Infants Under One Year
- Caltech: How Seasonal Flu Gained Tamiflu Resistance
- Eurosurveillance: Adverse Effects of Oseltamivir in Children
- NIH: Rapid Development Of Antiviral Resistance In Two Cases
- The Path Of Increased Resistance
- UK: National Pandemic Flu Service Stands Down
- WER Review: Oseltamivir Resistance In Pandemic H1N1
- South Korea Reports A Tamiflu-Resistant H1N1 Fatality
- Referral: Effect Measure On The BMJ Tamiflu Story
Widget by [ Iptek-4u ]